About US
Contact us
-
Merck announces changes to high-dose simvastatin prescribing information in the U.S.Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced changes to the prescribing information in the United States for the highest dose of simvastatin, 80 mg, and the use2011/6/10
-
Respira introduces breakthrough Dry Powder InhalerRespira Therapeutics, a product development company focused on inhaled therapeutics to improve patients' lives, introduces the company's Dry Powder Inhaler (DPI) as a breakthrough solution for the pha2011/6/10
-
Moody's Predicts Downturn for the Pharma IndustryGlobal credit rating agency Moody's has predicted a negative outlook for the pharmaceutical industry as a number of patents are due to expire, increasing pressure on large drug companies. Moody's b2011/6/9
-
SFDA issues the No.148 announcement of drug administrative protectionThe State Food and Drug Administration (SFDA) issued the No.148 Drug Administrative Protection Announcement on June 2, 2011, declaring the ending of drug administrative protection for Bracco S.P.A.’s2011/6/8
-
Bayer HealthCare seeks EU marketing authorization of VEGF Trap-Eye for treatment of wet AMDRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that Bayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the t2011/6/8
-
FDA grants orphan drug designation for Aradigm's ciprofloxacin to manage bronchiectasisAradigm Corporation (OTCBB:ARDM) (the "Company") today announced it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for ciprofloxacin for inhalation for the manag2011/6/7
-
Several drug makers plan to lower prices of vaccines for GAVI purchaseSeveral pharmaceutical companies have pledged to lower the prices of vaccines against childhood illnesses ahead of the GAVI Alliance conference in London next week, the Guardian reports (Quinn, 6/6).2011/6/7
-
PQA honors Kaiser Permanente for outstanding performance in medication safetyKaiser Permanente Colorado is one of only three health plans in the nation to receive a top honor for excellence in medication safety. The award, issued by the Pharmacy Quality Alliance, recognizes Ka2011/6/3
-
FDA approves Mylan's ANDA for Venlafaxine HCl ER Capsules to treat depressive, anxiety disorderMylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applic2011/6/3
-
Spanish Medicines Agency grants IMP License to Midatech's clinical grade nanoparticlesMidatech Biogune S. L., the nanoparticle manufacturing subsidiary of the Midatech Group, a global leader and centre of excellence for the design, development, synthesis and manufacture of nanomedicine2011/6/2